FDA Enforcement Class III Terminated

CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia

Recall: Z-1773-2019 · Reported June 19, 2019

Enforcement

Recall Number
Z-1773-2019
Event ID
82803
Classification
Class III
Status
Terminated
Product Type
Devices
Firm
Cardiocommand Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 19, 2019
Initiation Date
May 10, 2019
Classification Date
June 12, 2019
Termination Date
April 12, 2021
Address
4920 W Cypress St Ste 110, N/A, Tampa, FL, 33607-3837, United States

Description

CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia

Reason

Possible corrosion of the battery contact(s).

Code Info

Serial Numbers: 8059, 8060, 8022, 8063, 8211

Distribution

US Nationwide distribution in the states of CT, VW, OH, IL, DE.

Quantity

5 units